FR2001491B1 - - Google Patents

Info

Publication number
FR2001491B1
FR2001491B1 FR696902897A FR6902897A FR2001491B1 FR 2001491 B1 FR2001491 B1 FR 2001491B1 FR 696902897 A FR696902897 A FR 696902897A FR 6902897 A FR6902897 A FR 6902897A FR 2001491 B1 FR2001491 B1 FR 2001491B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR696902897A
Other versions
FR2001491A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2001491A1 publication Critical patent/FR2001491A1/fr
Application granted granted Critical
Publication of FR2001491B1 publication Critical patent/FR2001491B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/60—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 3 and 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
FR696902897A 1968-02-07 1969-02-07 Expired FR2001491B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70352368A 1968-02-07 1968-02-07
US79084269A 1969-01-13 1969-01-13
US79088669A 1969-01-13 1969-01-13

Publications (2)

Publication Number Publication Date
FR2001491A1 FR2001491A1 (fr) 1969-09-26
FR2001491B1 true FR2001491B1 (fr) 1973-07-13

Family

ID=27418758

Family Applications (3)

Application Number Title Priority Date Filing Date
FR696902897A Expired FR2001491B1 (fr) 1968-02-07 1969-02-07
FR7107345A Expired FR2085656B1 (fr) 1968-02-07 1971-03-03
FR7107344A Expired FR2095486A5 (fr) 1968-02-07 1971-03-03

Family Applications After (2)

Application Number Title Priority Date Filing Date
FR7107345A Expired FR2085656B1 (fr) 1968-02-07 1971-03-03
FR7107344A Expired FR2095486A5 (fr) 1968-02-07 1971-03-03

Country Status (11)

Country Link
JP (3) JPS524558B1 (fr)
BE (1) BE728053A (fr)
CH (1) CH534694A (fr)
DK (1) DK140726B (fr)
FI (1) FI56535C (fr)
FR (3) FR2001491B1 (fr)
GB (2) GB1265332A (fr)
IL (2) IL41553A (fr)
LU (1) LU57932A1 (fr)
NL (1) NL173407C (fr)
SE (3) SE384511B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1360860A (en) * 1970-07-08 1974-07-24 Ciba Geigy Ag Cepham compounds process for their manufacture and compositions containing them
JPS53164082U (fr) * 1977-05-31 1978-12-22
JPS5899787U (ja) * 1981-12-28 1983-07-07 奥野電器株式会社 ランプ用ソケツト
EP0300546B1 (fr) * 1987-07-10 1995-08-09 Gist-Brocades N.V. Dérivés de céphalosporine et procédé pour la préparation de composés céphem

Also Published As

Publication number Publication date
FI56535C (fi) 1980-02-11
GB1265332A (fr) 1972-03-01
NL173407C (nl) 1984-01-16
SE7512818L (sv) 1975-11-14
GB1265333A (fr) 1972-03-01
SE418616B (sv) 1981-06-15
JPS4924076B1 (fr) 1974-06-20
SE407064B (sv) 1979-03-12
FR2095486A5 (fr) 1972-02-11
NL173407B (nl) 1983-08-16
NL6902013A (fr) 1969-08-11
FR2085656A1 (fr) 1971-12-31
JPS524558B1 (fr) 1977-02-04
CH534694A (de) 1973-03-15
DK140726B (da) 1979-11-05
IL40447A (en) 1976-02-29
FI56535B (fi) 1979-10-31
BE728053A (fr) 1969-08-07
IL41553A (en) 1976-02-29
DK140726C (fr) 1980-03-31
LU57932A1 (fr) 1969-09-17
JPS524559B1 (fr) 1977-02-04
FR2001491A1 (fr) 1969-09-26
SE384511B (sv) 1976-05-10
FR2085656B1 (fr) 1974-08-23

Similar Documents

Publication Publication Date Title
AU1946070A (fr)
AU428130B2 (fr)
AU2374870A (fr)
AU5184069A (fr)
AU6168869A (fr)
JPS524558B1 (fr)
AU6171569A (fr)
AU416157B2 (fr)
AU429879B2 (fr)
AU2581067A (fr)
AU4811568A (fr)
AU421558B1 (fr)
AU3224368A (fr)
AR203075Q (fr)
AU2580267A (fr)
AU4744468A (fr)
AU3789668A (fr)
AU479393A (fr)
BE708888A (fr)
AU463027A (fr)
AU4503667A (fr)
AU4270368A (fr)
AU479894A (fr)
NL6916458A (fr)
AU4464266A (fr)